Cargando…
Patient Derived Ex-Vivo Cancer Models in Drug Development, Personalized Medicine, and Radiotherapy
SIMPLE SUMMARY: This review article highlights gaps in the current system of drug development and personalized medicine for cancer therapy. The ex vivo model system using tissue biopsy from patients will advance the development of the predictive disease specific biomarker, drug screening and assessm...
Autores principales: | Zitter, Ryan, Chugh, Rishi Man, Saha, Subhrajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220792/ https://www.ncbi.nlm.nih.gov/pubmed/35740672 http://dx.doi.org/10.3390/cancers14123006 |
Ejemplares similares
-
Human Peripheral Blood Mononucleocyte Derived Myeloid Committed Progenitor Cells Mitigate H-ARS by Exosomal Paracrine Signal
por: Chugh, Rishi Man, et al.
Publicado: (2022) -
Experimental Models to Study COVID-19 Effect in Stem Cells
por: Chugh, Rishi Man, et al.
Publicado: (2021) -
Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine
por: Chen, Jia-Yang, et al.
Publicado: (2022) -
Organotypic human ex vivo models for coronavirus disease 2019 research and drug development
por: Youhanna, Sonia, et al.
Publicado: (2021) -
Deep Morphology Learning Enhances Ex Vivo Drug
Profiling-Based Precision Medicine
por: Heinemann, Tim, et al.
Publicado: (2022)